STOCK TITAN

Millennium Group (OMCL) discloses 2,288,570 shares, a 5.0% holding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Omnicell, Inc. Schedule 13G discloses that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report shared beneficial ownership of 2,288,570 shares of Omnicell common stock, representing 5.0% of the class. The filing is a joint filing and is signed by the reporting parties.

The filing states the shares are held by entities over which reporting persons have voting and investment discretion and provides the reporting persons' addresses and citizenships. Exhibit I is a Joint Filing Agreement dated March 31, 2026.

Positive

  • None.

Negative

  • None.

Insights

Joint holders report a 5.0% shared stake via Millennium-related entities.

The filing lists 2,288,570 shares as shared voting and dispositive power among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. This identifies a non‑controlling but notable passive stake disclosed under Schedule 13G conventions.

Key dependencies include the holdings being held through affiliated entities and governed by a Joint Filing Agreement dated March 31, 2026. Subsequent filings may update percent ownership if positions change.

Shared beneficial ownership 2,288,570 shares reported on Schedule 13G (joint filing)
Percent of class 5.0% percentage of Omnicell common stock reported
Joint Filing Agreement date March 31, 2026 Exhibit I to Schedule 13G
Schedule 13G regulatory
"Signed: Schedule 13G discloses beneficial ownership details"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Shared Dispositive Power financial
"Shared Dispositive Power 2,288,570.00"
Joint Filing Agreement legal
"Exhibit I: Joint Filing Agreement, dated as of March 31, 2026"





68213N109

(CUSIP Number)
03/25/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:03/31/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:03/31/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:03/31/2026
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of March 31, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

FAQ

What stake does Millennium Management report in OMCL?

The filing reports a shared beneficial ownership of 2,288,570 shares, equal to 5.0% of Omnicell's common stock, held by Millennium‑related entities and Israel A. Englander.

Who signed the Schedule 13G for OMCL?

The Schedule 13G is signed by Gil Raviv as Global General Counsel for Millennium entities and by Israel A. Englander, with signatures dated March 31, 2026.

Are the reported shares held directly by the filers?

The filing states the shares are held by entities subject to voting and investment discretion of Millennium Management LLC and related managers; direct ownership is attributed to those entities.

What document governs the joint filing of the OMCL position?

Exhibit I is a Joint Filing Agreement among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander, dated March 31, 2026.

What is the reporting class and CUSIP for the OMCL filing?

The class reported is Common Stock, par value $0.001 and the CUSIP listed is 68213N109 on the Schedule 13G cover.